GGrantIndex
← Leaderboards

Summer S Han

Stanford University

$6,639,965
Attributed
$6,639,965
Total exposure
3
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.4M · FY201825
$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,639,965 · 3

By mechanism

R37$4,335,254 · 1
R01$1,914,078 · 1
P01$390,633 · 1

Top collaborators

No co-investigators on record.

Most similar at Stanford University

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Research Personnel

Research focus

Research PersonnelScreening GuidelinesCessation Of LifeRisk FactorsMalignant Neoplasm Of LungMortalityHigh RiskLung Cancer ScreeningPublic HealthDiagnosisComputed Tomography ScreeningFollow-UpConsensusMorbidity - Disease RateScreeningGeneticCancer SurvivorCost SavingsLungPredictive ModelingSmokingCancer EtiologyCancer RiskStandard Of Care

Grant awards (13)

Integrating Multiple Electronic Health Records Systems to Improve Lung Cancer Outcomes$643,402
R01 · FY2025 · CA · contact PI
Core C: Biostatistics$132,421
P01 · FY2025 · CA · contact PI
Evaluation of genetic, clinical and environmental risk factors to establish effective screening strategies for second primary lung cancer$621,799
R37 · FY2024 · CA · contact PI
Integrating Multiple Electronic Health Records Systems to Improve Lung Cancer Outcomes$611,784
R01 · FY2024 · CA · contact PI
Core C: Biostatistics$125,797
P01 · FY2024 · CA · contact PI
Integrating Multiple Electronic Health Records Systems to Improve Lung Cancer Outcomes$658,892
R01 · FY2023 · CA · contact PI
Evaluation of genetic, clinical and environmental risk factors to establish effective screening strategies for second primary lung cancer$648,460
R37 · FY2023 · CA · contact PI
Core C: Biostatistics$132,415
P01 · FY2023 · CA · contact PI
Evaluation of genetic, clinical, and environmental risk factors to establish effective screening strategies for second primary lung cancer$574,350
R37 · FY2022 · CA · contact PI
Evaluation of genetic, clinical, and environmental risk factors to establish effective screening strategies for second primary lung cancer$589,771
R37 · FY2021 · CA · contact PI
Evaluation of genetic, clinical, and environmental risk factors to establish effective screening strategies for second primary lung cancer$605,892
R37 · FY2020 · CA · contact PI
Evaluation of genetic, clinical, and environmental risk factors to establish effective screening strategies for second primary lung cancer$602,532
R37 · FY2019 · CA · contact PI
Evaluation of genetic, clinical, and environmental risk factors to establish effective screening strategies for second primary lung cancer$692,450
R37 · FY2018 · CA · contact PI